Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Relay Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RLAY
Nasdaq
8731
https://relaytx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Relay Therapeutics Inc
Strength Seen in Relay Therapeutics (RLAY): Can Its 6.7% Jump Turn into More Strength?
- Sep 17th, 2024 12:24 pm
Why Relay Therapeutics Plummeted by Nearly 14% Today
- Sep 11th, 2024 10:46 pm
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
- Sep 11th, 2024 12:21 am
Relay Stock Soars on Upbeat Data From Breast Cancer Study
- Sep 10th, 2024 2:55 pm
Relay Therapeutics Announces Proposed Public Offering of Common Stock
- Sep 9th, 2024 8:34 pm
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
- Sep 9th, 2024 3:30 pm
Relay breast cancer drug shows potential in early trial
- Sep 9th, 2024 12:07 pm
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
- Sep 9th, 2024 10:55 am
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
- Sep 6th, 2024 8:05 pm
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
- Aug 6th, 2024 8:05 pm
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
- Jul 30th, 2024 8:05 pm
We're Not Very Worried About Relay Therapeutics' (NASDAQ:RLAY) Cash Burn Rate
- Jul 24th, 2024 1:46 pm
Caribou lays off staff; Roche walks away from Relay
- Jul 17th, 2024 11:45 am
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
- Jun 6th, 2024 11:00 am
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
- Jun 5th, 2024 8:05 pm
Relay Therapeutics to Participate in Upcoming Investor Conferences
- May 21st, 2024 8:05 pm
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
- May 13th, 2024 12:30 pm
Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations
- May 4th, 2024 1:11 pm
Relay Therapeutics Outperforms Revenue Expectations in Q1 2024
- May 2nd, 2024 9:55 pm
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
- May 2nd, 2024 9:40 pm
Scroll